SCHEMBL891062

SCHEMBL891062

SCOc1cccc(OCS)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 2/20 0.45
CYP3A4 P08684 2/20 0.45
TSHR P16473 2/20 0.45
HIF1A Q16665 2/20 0.45
ALDH1A1 P00352 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
MAOB P27338 9/20 0.42
LMNA P02545 1/20 0.41
MAPK1 P28482 2/20 0.39
APP P05067 1/20 0.38
HDAC3 O15379 1/20 0.38
HDAC4 P56524 1/20 0.38
HDAC1 Q13547 1/20 0.38
HDAC7 Q8WUI4 1/20 0.38
HDAC2 Q92769 1/20 0.38
HDAC10 Q969S8 1/20 0.38
HDAC11 Q96DB2 1/20 0.38
HDAC8 Q9BY41 1/20 0.38
HDAC6 Q9UBN7 1/20 0.38
HDAC9 Q9UKV0 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7006482 0.84 ACHE (0.56) ALDH1A1MAOBLMNA
SCHEMBL5828015 0.84 CYP3A4 (0.64) TP53CYP3A4TSHRALDH1A1SMN1; SMN2
SCHEMBL890749 0.82 ALDH1A1 (0.33) ALDH1A1
SCHEMBL4710446 0.80
SCHEMBL890649 0.79 HDAC3 (0.50) TP53CYP3A4TSHRHIF1AALDH1A1
SCHEMBL22367633 0.77 HDAC3 (0.59) TSHRALDH1A1SMN1; SMN2LMNAMAPK1
SCHEMBL27571905 0.76 ALDH1A1 (0.34) TP53CYP3A4TSHRHIF1AALDH1A1
SCHEMBL890923 0.76 NQO1 (0.47) TSHRHIF1ALMNAAPPHDAC3
SCHEMBL22367630 0.75 HDAC3 (0.69) TSHRALDH1A1MAPK1HDAC3HDAC4
SCHEMBL3122665 0.74 MAPK1 (0.38) TP53CYP3A4TSHRSMN1; SMN2MAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 128 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260062512-A1 CURABLE COMPOSITION, CURED PRODUCT, AND METHOD FOR PRODUCING CURED PRODUCT KUREHA CORPORATION (JP) 2026-03-05 US disclosed
US-20260062548-A1 RUBBER-BONDED CELLULOSE FIBERS AND MANUFACTURING METHOD THEREFOR, RESIN COMPOSITION AND MANUFACTURING METHOD THEREFOR, AND CURABLE RESIN COMPOSITION KUREHA CORPORATION (JP) 2026-03-05 US disclosed
EP-4679147-A1 MULTILAYER BODY, OPTICAL ARTICLE, COATING LAYER-CONTAINING MULTILAYER BODY, LENS, EYEGLASSES, AND FILM FOR WINDOWS TOKUYAMA CORPORATION (JP) 2026-01-14 EP disclosed
US-20250355282-A1 LAYERED BODY, OPTICAL ARTICLE, LENS, AND SPECTACLES TOKUYAMA CORPORATION (JP) 2025-11-20 US disclosed
US-20250257162-A1 CURABLE COMPOSITION, CURED BODY, LAMINATE, OPTICAL ARTICLE, LENS, AND EYEGLASSES TOKUYAMA CORPORATION (JP) 2025-08-14 US disclosed
EP-4582459-A1 RUBBER-BONDED CELLULOSE FIBERS AND MANUFACTURING METHOD THEREFOR, RESIN COMPOSITION AND MANUFACTURING METHOD THEREFOR, AND CURABLE RESIN COMPOSITION Kureha Corporation (JP) 2025-07-09 EP disclosed
EP-4582463-A1 CURABLE COMPOSITION, CURED PRODUCT, AND METHOD FOR PRODUCING CURED PRODUCT Kureha Corporation (JP) 2025-07-09 EP disclosed
EP-4560367-A1 LAYERED BODY, OPTICAL ARTICLE, LENS, AND SPECTACLES TOKUYAMA CORPORATION (JP) 2025-05-28 EP disclosed
CN-119768447-A Curable composition, cured product, and method for producing cured product 株式会社吴羽 2025-04-04 CN disclosed
CN-119768439-A Rubber-bonded cellulose fiber, method for producing same, resin composition, method for producing same, and cured resin composition 株式会社吴羽 2025-04-04 CN disclosed
US-6673888-B2 PLASTIC LENSES HOYA CORPORATION (JP) 2004-01-06 US disclosed
EP-0751161-B1 Sulfur-containing urethane-based resin composition, optical element and lens comprising this resin MITSUI CHEMICALS INC (JP) 2003-01-02 EP disclosed
US-20020132954-A1 Optical materials having good ultraviolet absorbability and method for producing them KOSAKA MASAHISA (JP) 2002-09-19 US disclosed
US-6448304-B1 POLYURETHANE, POLYTHIOURETHANE OR DIETHYLENE GLYCOL BISALLYLCARBONATE POLYMER; DIPPING IN SOLUTION CONTAINING A DIBENZOYLMETHANE OR A BENZOTRIZOLE COMPOUND; PLASTIC LENS FOR SPECTACLES WHICH ABSORBS ULTRAVIOLET RAYS; LOW YELLOWNESS HOYA CORPORATION (JP) 2002-09-10 US disclosed
US-6441119-B1 POLYMERIZING A PLASTIC LENS MONOMER SUCH AS A DIETHYLENE GLYCOL, BISALLYL CARBONATE MIXED WITH THE UV ABSORBENT 2-(2-HYDROXY-4-OCTYLOXYPHENYL)-BENZOTRIAZOLE; NONYELLOWING; EYEGLASSES HOYA CORPORATION (JP) 2002-08-27 US disclosed
EP-1085349-A2 Plastic lenses having good ultraviolet absorbability, and method for the production thereof HOYA CORPORATION (JP) 2001-03-21 EP disclosed
EP-1085348-A2 Plastic lenses of good ultraviolet absorbability for spectacles and method for producing them HOYA CORPORATION (JP) 2001-03-21 EP disclosed
US-5955206-A POLYTHIOETHERS AND ACRYLATE OR VINYL GROUPS FOR CURING TO FORM OPTICAL LENSES MITSUI CHEMICALS, INC. (JP) 1999-09-21 US disclosed
EP-0751161-A2 Sulfur-containing urethane-based resin composition, optical element and lens comprising this resin MITSUI TOATSU CHEMICALS, Inc. (JP) 1997-01-02 EP disclosed
EP-0742244-A2 Durable polysulfide composition for optical material MITSUI TOATSU CHEMICALS, INC. (JP) 1996-11-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260062548-A1 RUBBER-BONDED CELLULOSE FIBERS AND MANUFACTURING METHOD THEREFOR, RESIN COMPOSITION AND MANUFACTURING METHOD THEREFOR, AND CURABLE RESIN COMPOSITION CROCC, WASF2, DCXR TP53 3730/4885CYP3A4 2467/4885TSHR 4622/4885
US-20260062512-A1 CURABLE COMPOSITION, CURED PRODUCT, AND METHOD FOR PRODUCING CURED PRODUCT EHMT1, EHMT2, ASH2L TP53 3008/4885CYP3A4 3027/4885TSHR 2894/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.